Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands.

[1]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[2]  Joshua Soldo,et al.  Evaluation of two automated immunoassays for 25-OH vitamin D: Comparison against LC–MS/MS , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[3]  Peter Szolovits,et al.  Normalization of Plasma 25-Hydroxy Vitamin D Is Associated with Reduced Risk of Surgery in Crohn’s Disease , 2013, Inflammatory bowel diseases.

[4]  A. Berg,et al.  Variation in clinical vitamin D status by DiaSorin Liaison and LC-MS/MS in the presence of elevated 25-OH vitamin D2. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[5]  Christopher-John L Farrell,et al.  25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays , 2012, Clinical chemistry and laboratory medicine.

[6]  J. Finkelstein,et al.  Prevalence and predictors of vitamin D deficiency in healthy adults. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  H. Wulf,et al.  The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: a randomized clinical trial , 2012, The British journal of dermatology.

[8]  K. Sikaris,et al.  Variability in vitamin D assays impairs clinical assessment of vitamin D status , 2012, Internal medicine journal.

[9]  J. Marshall,et al.  Management of inflammatory bowel disease with vitamin D: beyond bone health. , 2012, Journal of Crohn's & colitis.

[10]  B. Salh,et al.  Hypovitaminosis D in Adults with Inflammatory Bowel Disease: Potential Role of Ethnicity , 2012, Digestive Diseases and Sciences.

[11]  C. O'Morain,et al.  Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting. , 2012, Journal of Crohn's & colitis.

[12]  M. Hur,et al.  Comparison of four current 25-hydroxyvitamin D assays. , 2012, Clinical biochemistry.

[13]  E. Giovannucci,et al.  Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. , 2012, Gastroenterology.

[14]  R. Habib,et al.  25-hydroxyvitamin D assay variations and impact on clinical decision making. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  J. Hugot,et al.  Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. , 2011, Gastroenterology.

[16]  F. Farraye,et al.  Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease1,2,3 , 2011, Inflammatory bowel diseases.

[17]  Matthew D Krasowski,et al.  Pathology consultation on vitamin D testing. , 2011, American journal of clinical pathology.

[18]  C. Gordon,et al.  Prevalence and Risk Factors for Hypovitaminosis D in Young Patients With Inflammatory Bowel Disease , 2011, Journal of pediatric gastroenterology and nutrition.

[19]  A. Ananthakrishnan,et al.  Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[20]  M. Boutron‐Ruault,et al.  Low exposure to sunlight is a risk factor for Crohn’s disease , 2011, Alimentary pharmacology & therapeutics.

[21]  J. Walters,et al.  Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer , 2011, Therapeutic advances in gastroenterology.

[22]  A. van de Wiel,et al.  Seasonal variation of serum 25-hydroxyvitamin D levels in adult patients with inflammatory bowel disease , 2010, Osteoporosis International.

[23]  K. Glanz,et al.  Validity of Self-reported Solar UVR Exposure Compared with Objectively Measured UVR Exposure , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  J. M. van den Ouweland,et al.  Measurement of 25-OH-vitamin D in human serum using liquid chromatography tandem-mass spectrometry with comparison to radioimmunoassay and automated immunoassay. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[25]  Sihe Wang.  Epidemiology of vitamin D in health and disease , 2009, Nutrition Research Reviews.

[26]  M. Bronze,et al.  Osteoporosis in inflammatory bowel disease. , 2009, The American journal of medicine.

[27]  T. Chiba,et al.  High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease , 2009, Osteoporosis International.

[28]  M. Clerici,et al.  Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on TH1/TH2 Cytokines in Inflammatory Bowel Disease: An in Vitro Study , 2009, International journal of immunopathology and pharmacology.

[29]  G. Carter,et al.  Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D , 2009, Annals of clinical biochemistry.

[30]  Glenville Jones.  Pharmacokinetics of vitamin D toxicity. , 2008, The American journal of clinical nutrition.

[31]  P. Karran,et al.  Azathioprine treatment photosensitizes human skin to ultraviolet A radiation , 2008, The British journal of dermatology.

[32]  C. Apovian,et al.  American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[33]  W. Leslie,et al.  Vitamin D Status and Bone Density in Recently Diagnosed Inflammatory Bowel Disease: The Manitoba IBD Cohort Study , 2008, The American Journal of Gastroenterology.

[34]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[35]  K. Glanz,et al.  Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. , 2008, Archives of dermatology.

[36]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[37]  T. Dwyer,et al.  Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia , 2007, Journal of Neurology.

[38]  W. Willett,et al.  The urgent need to recommend an intake of vitamin D that is effective. , 2007, The American journal of clinical nutrition.

[39]  C. Gordon,et al.  Vitamin D Status in Children and Young Adults With Inflammatory Bowel Disease , 2006, Pediatrics.

[40]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[41]  F. Carbonnel,et al.  Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data , 2006, Inflammatory bowel diseases.

[42]  Joshy Jacob,et al.  Interleukin-10 plays an early role in generating virus-specific T cell anergy , 2006, BMC Immunology.

[43]  M. Kiely,et al.  Seasonality of vitamin D status and bone turnover in patients with Crohn's disease , 2005, Alimentary pharmacology & therapeutics.

[44]  H. Drummond,et al.  Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. , 2004, Gastroenterology.

[45]  M. Drezner,et al.  Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. , 2004, The Journal of clinical endocrinology and metabolism.

[46]  Masahiko Kato,et al.  Risk factors for vitamin D deficiency in patients with Crohn’s disease , 2004, Journal of Gastroenterology.

[47]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[48]  H. Steinhart,et al.  The frequency of vitamin D deficiency in adults with Crohn's disease. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[49]  M. Cantorna,et al.  The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells , 2003, Journal of cellular biochemistry.

[50]  M. Schwab,et al.  6‐Thioguanine — efficacy and safety in chronic active Crohn's disease , 2003, Alimentary pharmacology & therapeutics.

[51]  B. Zemel,et al.  Vitamin D status in children, adolescents, and young adults with Crohn disease. , 2002, The American journal of clinical nutrition.

[52]  J. Jahnsen,et al.  Vitamin D Status, Parathyroid Hormone and Bone Mineral Density in Patients with Inflammatory Bowel Disease , 2002, Scandinavian journal of gastroenterology.

[53]  Huub F. J. Savelkoul,et al.  1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4+ T Cells to Enhance the Development of Th2 Cells1 , 2001, The Journal of Immunology.

[54]  P. Lips,et al.  Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.

[55]  M. Holick,et al.  Decreased bioavailability of vitamin D in obesity. , 2000, The American journal of clinical nutrition.

[56]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[57]  Looker Ac,et al.  Hypovitaminosis D in medical inpatients. , 1998 .

[58]  J. Bengoa,et al.  Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. , 1991, The American journal of clinical nutrition.

[59]  M. Holick,et al.  Sunscreens suppress cutaneous vitamin D3 synthesis. , 1987, The Journal of clinical endocrinology and metabolism.

[60]  R. Kumar,et al.  Enterohepatic physiology of 1,25-dihydroxyvitamin D3 metabolites in normal man. , 1980, The Journal of laboratory and clinical medicine.

[61]  Graham D Carter,et al.  Accuracy of 25-hydroxyvitamin D assays: confronting the issues. , 2011, Current drug targets.

[62]  M. Faure,et al.  Samenvatting en aanbevelingen , 2006 .

[63]  C. Bell,et al.  Ultraviolet light may contribute to geographic and racial blood pressure differences. , 1998, Hypertension.

[64]  M. Holick,et al.  Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry. , 1993, Biological mass spectrometry.

[65]  A. Sonnenberg,et al.  Geographic variation of inflammatory bowel disease within the United States. , 1991, Gastroenterology.